Hormone Replacement Therapy in Women with Epilepsy: A Randomized, Double‐Blind, Placebo‐Controlled Study

Summary:  Purpose: Previous reports have suggested that hormone replacement therapy (HRT) could increase seizure activity in women with epilepsy. We sought to determine whether adding HRT to the medication regimen of postmenopausal women with epilepsy was associated with an increase in seizure frequency.

[1]  A. Herzog Progesterone therapy in women with complex partial and secondary generalized seizures , 1995, Neurology.

[2]  A. Herzog Progesterone therapy in women with epilepsy: A 3-year follow-up , 1999, Neurology.

[3]  M. Sperling,et al.  Relationships Between Seizure Severity and Health‐Related Quality of Life in Refractory Localization‐Related Epilepsy , 2000, Epilepsia.

[4]  A. Walf,et al.  Progesterone Reduces Pentylenetetrazol‐Induced Ictal Activity of Wild‐Type Mice But Not Those Deficient in Type I 5α‐Reductase , 2002, Epilepsia.

[5]  M. Rogawski,et al.  Neurosteroid Withdrawal Model of Perimenstrual Catamenial Epilepsy , 2001, Epilepsia.

[6]  T. Tomson,et al.  Oral contraceptives reduce lamotrigine plasma levels , 2003, Neurology.

[7]  L. Giudice,et al.  Predictors of ovulatory failure in women with epilepsy , 2002, Annals of neurology.

[8]  Ailsa E Gebbie,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative Randomized Controlled Trial. Writing Group for the Women's Health Initiative Investigators. JAMA 2002; 288(3): 321-333 , 2002, Journal of Family Planning and Reproductive Health Care.

[9]  G. G. Buterbaugh,et al.  Estrogen Alters the Acquisition of Seizures Kindled by Repeated Amygdala Stimulation or Pentylenetetrazol Administration in Ovariectomized Female Rats , 1986, Epilepsia.

[10]  L. Ravdin,et al.  The Effect of Menopause and Perimenopause on the Course of Epilepsy , 1999, Epilepsia.

[11]  W. Burnham,et al.  The Anticonvulsant Effects of Progesterone and 5α‐dihydroprogesterone on Amygdala‐kindled Seizures in Rats , 2003, Epilepsia.

[12]  I. Leppik,et al.  Lamotrigine clearance during pregnancy , 2002, Neurology.

[13]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[14]  Harold,et al.  Estrogen Actions Throughout the Brain , 2002 .

[15]  Michael Seidenberg,et al.  The Relative Impact of Anxiety, Depression, and Clinical Seizure Features on Health‐related Quality of Life in Epilepsy , 2004, Epilepsia.

[16]  P. Pennell,et al.  Frequency of catamenial seizure exacerbation in women with localization‐related epilepsy , 2004, Annals of neurology.

[17]  P. Pennell,et al.  The impact of pregnancy and childbirth on the metabolism of lamotrigine , 2004, Neurology.

[18]  M. Engelsman,et al.  Gestation-induced changes in lamotrigine pharmacokinetics: A monotherapy study , 2004, Neurology.